Targeted Oncology

Targeted Oncology


Oncology news and insight from leading researchers and cancer centers.

11695 followers  •  3156 follow  •  Eastern Time (US & Canada)  •   http://targetedonc.com

No result

snDNLBAbc4308cd028711069fb230442437d6f5

A supplemental Biologics License Application for the combination of nivolumab and ipilimumab for the treatment of patients with advanced HCC previously treated with sorafenib has been accepted by the FDA and given Priority Review status. #livercancer 

Loading
Loading